Medinteract

Por el conocimiento de las Interacciones Farmacológicas

[Medinteract @Medinteract]

Pharmacokinetic Drug-Drug Interaction With Coadministration of Cannabidiol and Everolimus in a Phase 1 Healthy Volunteer Trial. https://t.co/kKnvmlQLE3

[Medinteract @Medinteract]

P‐Glycoprotein Mediated Interaction is A Risk Factor For Qt Prolongation in Concomitant Use of Antipsychotics and Ssris As P‐Glycoprotein Mediated Inhibitors: Analysis of The Japanese Adverse Drug Event Report Database https://t.co/XnDrMeI0oV

[HIV Drug Interactions @hivinteractions]

Be part of the record-breaking 24th edition of the #ANTIVIRALPK 2023 in Rome!
Exciting lectures from an exceptional lineup of speakers and interactive sessions awaits you from 11th to 13th September in Rome.
Register here: https://t.co/iPdw3dfxTW
#ANTIVIRALPK #Pharmacology

[Medinteract @Medinteract]

Os enviamos este mail para informaros que tenéis disponible el nuevo libro de MEDINTERACT: Interacciones Farmacológicas delTratamiento Oncológico.

Podéis acceder a él, gratuitamente, a través de biblioteca virtual de la SEFH: https://t.co/XVY8LCMn15. #sefh

[Medinteract @Medinteract]

Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer https://t.co/mYnhMaQ01n

[Medinteract @Medinteract]

Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria | Antimicrobial Agents and Chemotherapy https://t.co/qhIOSymRVM

[Medinteract @Medinteract]

Cabozantinib carries the risk of drug-drug interactions via inhibition of UDP-glucuronosyltransferase (UGT) 1A9 https://t.co/LlZqEgajNU

[Medinteract @Medinteract]

Cannabidiol drug interaction considerations for prescribers and pharmacists https://t.co/6Vg3MmGxqK

[Medinteract @Medinteract]

Important roles of transporters in the pharmacokinetics of anti-viral nucleoside/nucleotide analogs - https://t.co/opPWIPhFlI #ScholarAlerts

[Medinteract @Medinteract]

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database - https://t.co/eXg62Azlb6 #ScholarAlerts

[Medinteract @Medinteract]

Nuevas interacciones en https://t.co/UccFK7HGfI.

[Medinteract @Medinteract]

Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteer https://t.co/bcfwZmwagi

[Medinteract @Medinteract]

Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) https://t.co/ka21R8Dn6z

[Medinteract @Medinteract]

Activation of GLP-1 receptor signalling by sacubitril/valsartan: Implications for patients with poor glycaemic control https://t.co/Og8KYATzsX

[Medinteract @Medinteract]

Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate among transgender adolescents... - https://t.co/szOJSpljgS #ScholarAlerts

[Medinteract @Medinteract]

Drug Interactions Associated With Therapies for Pulmonary Arterial Hypertension - https://t.co/DA4ONPezOg #ScholarAlerts

[Medinteract @Medinteract]

First-generation Oral Antivirals Against SARS-CoV-2 - https://t.co/z6Eu0xlkUi

[Medinteract @Medinteract]

Dolutegravir: Background, Pharmacokinetics, Adverse Drug Reactions, Drug Interactions, Pregnancy... - https://t.co/SuJLGkPXmM #ScholarAlerts

[Medinteract @Medinteract]

Clinical pharmacology of metoclopramide in infants and children - https://t.co/0DCHc56YKT

[Medinteract @Medinteract]

Effect of enzalutamide on PK of P-gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters: https://t.co/Vx9HZJSccV